About PPA   |   Contact Us   |   Sign In   |   Join Now
Online Store: CE Activities
Main Storefront
        

Proton-Pump Inhibitors: Navigating the Jungle of Risks and Benefits

Item Options
Sign in for your pricing!
Price: $30.00
Quantity: *
Select Your Profession:
*
 
In order to receive CE credit for this activity, you MUST provide your CPE Monitor ID and birthday here. To look up (or sign up for) your CPE Monitor ID, visit www.mycpemonitor.net.
 
Please enter your response below: *
(of 255 characters remaining)
Description
Non-Member Access fee for Recorded CE Webinar:

 

Non-members are invited to view recorded webinars and receive CE credit for a small fee.

 

Once your payment has been processed, you will receive an automated email with a link to download an electronic item. Click the link in the email - this will download a PDF file that contains a link to access the recorded webinar.

 

Please contact PPA's CPE Administrator, Sara Bowden, at (717) 234-6151 x. 2 or sbowden@papharmacists.com with questions.

  


Activity Details

Proton-Pump Inhibitors: Navigating the Jungle of Risks and Benefits

Please read the following information about this continuing pharmacy education (CPE) activity before purchasing.


UAN: 0159-0000-17-502-H01-P

Release Date: January 12, 2018
Expiration Date: September 22, 2020

Activity Type: Application-based

CE Credit: 1 Contact Hour (0.1 CEU)

Cost: Free for PPA Members, $30 for non-members

The Pennsylvania Pharmacists Association is accredited by the Accreditation
Council for Pharmacy Education as a provider of continuing pharmacy education.
Target Audience

All pharmacists

Program Description

There has been an increased volume of alerts regarding the risks associated with use of proton-pump inhibitors (PPIs). This program will provide guidance on balancing the risks and benefits associated with chronic PPI therapy. It will also offer tools to evaluate the appropriateness of PPI therapy. Patient cases will be utilized to demonstrate the concepts and aid in the application of said concepts to future patients.


Program Objectives

1. Discuss indications, pharmacokinetics, and adverse effects of proton pump inhibitors (PPIs)
2. Recognize potential risks of chronic treatment with PPIs
3. Evaluate the appropriateness of PPI therapy in a patient scenario

Presenter

Chelsea Bombatch, PharmD, BCPS, Clinical Pharmacist Educator at RxPrep

Dr. Chelsea Bombatch is a board certified clinical pharmacist educator with RxPrep. In this role, she develops review materials for students preparing for their NAPLEX exam and travels to schools of pharmacy to teach live review courses. Prior to working at RxPrep, she was a clinical pharmacist with the Washington Health System. She completed a PGY1 residency at UPMC Presbyterian followed by a PGY2 residency in ambulatory care at the Cleveland Clinic. She has authored and contributed to a number of scholarly publications regarding a wide variety of topics, including herpes zoster vaccine in patients with HIV, pediatric asthma and cystic fibrosis, and Prader-Willi syndrome.


CE Requirements

To receive CE credit for this home study, you will need to watch the entire video, complete an online survey evaluation, and pass a short quiz. Access to the survey and quiz will be automatically provided after you have watched the video. PPA must have your CPE Monitor ID and birthday on file to issue credit.

 

Disregard instructions given in the video on receiving credit. CE Credit will be sent to CPE Monitor early next month.


Association Management Software Powered by YourMembership  ::  Legal